CONMED | CNMD - Ordinary Share Capital


CONMED reported $30.97M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
3M USD 521.57M 8.71M Mar/2026
Abbott USD 1.74B 23.39B Sep/2025
Accuray USD 100K 1000 Sep/2024
AtriCure USD 49.79M 91K Dec/2025
Avanos Medical USD 46.67M 216.61K Mar/2026
Baxter International USD 516.45M 2.17M Mar/2026
Becton, Dickinson and Co. USD 284.91M 1.72M Dec/2025
Boston Scientific USD 1.48B 2.66M Dec/2025
CONMED USD 30.97M 16K Dec/2025
Cooper Companies USD 195.11M 14K Mar/2026
Dexcom USD 385.9M 1.1M Mar/2026
Edwards Lifesciences USD 580.7M 0 Dec/2025
Globus Medical USD 135.06M 449K Dec/2025
Inogen USD 23K 0 Dec/2023
Insulet USD 69.26M 1.08M Mar/2026
Integra LifeSciences USD 77.82M 69K Mar/2026
Intuitive Surgical USD 355.17M 674K Mar/2026
J&J USD 2.41B 1.74M Dec/2025
Medtronic USD 1.28B 1.38M Dec/2025
Merit Medical Systems USD 59.65M 231K Mar/2026
Olympus JPY 1.1B 35.42K Mar/2026
Orthofix International USD 39.83M 315K Dec/2025
ResMed USD 190.83M 44.86M Mar/2026
Smith & Nephew USD 875.96M 1.61M Dec/2025
Steris USD 98.07M 72K Mar/2026
Stryker USD 382.98M 584K Mar/2026
Tandem Diabetes Care USD 68.29M 518K Dec/2025
Teleflex USD 44.26M 70K Mar/2026
Zimmer Biomet Holdings USD 195.5M 2.68M Mar/2026